Subscribe Now Subscribe Today
Research Article
 

Evaluation of Methods for Detection of Clostridium difficile and its Toxins in Patients with Nosocomial Diarrhoea



N. Sadeghifard , M.H. Salari , M.R. Ghasemi and F. Amin-Harati
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

The aim of this study was to compare stool cytotoxin assay as the standard test with enzyme immunoassay system (C. difficile Tox A/B Tech Lab) and C. difficile bacterial culture on cycloserine-cefoxitin fructose agar followed by cytotoxin assay (toxigenic culture). A total of 650 stool specimens from hospitalized patients with nosocomial diarrhoea were collected from December 2002 to February 2004. C. difficile was detected by culture method in 146 samples. Of these samples 103 isolates were toxigenic by toxigenic culture. One hundred twelve and 108 stool specimens were positive for C. difficile toxins by enzyme immunoassay (Tox A/B immunoassay) and stool cytotoxin assay, respectively. Ninety eight samples were diagnosed to be positive in all test methods. Toxigenic C. difficile was isolated from 2 stool cytotoxin assay and 3 enzyme immunoassay negative stools. Sensitivity and specificity for Tox A/B immunoassay in relation to the stool cytotoxin assay was 95.6% (95% CI) and 98.3% (95% CI), respectively. The results of the present study showed that sensitivity and specificity Tox A/B immunoassay was very close with stool cytotoxin assay.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

N. Sadeghifard , M.H. Salari , M.R. Ghasemi and F. Amin-Harati , 2005. Evaluation of Methods for Detection of Clostridium difficile and its Toxins in Patients with Nosocomial Diarrhoea. Pakistan Journal of Biological Sciences, 8: 1256-1260.

DOI: 10.3923/pjbs.2005.1256.1260

URL: https://scialert.net/abstract/?doi=pjbs.2005.1256.1260

REFERENCES
1:  Bartlett, J.G., 1994. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin. Infect. Dis., 18: 265-272.

2:  Limaye, A.P., D.K. Turgeon, B.T. Cookson and T.R. Fritsche, 2000. Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. J. Clin. Microbiol., 38: 1696-1697.
Direct Link  |  

3:  Surawicz, C.M., 1998. Clostridium difficile disease: Diagnosis and treatment. Gastroenterologist, 6: 60-65.
PubMed  |  

4:  Johnson, S. and D.N. Gerding, 1998. Clostridium difficile-associated diarrhea. Clin. Infect. Dis., 26: 1027-1036.

5:  Gerding, D.N., 1997. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?. Clin. Infect. Dis., 25: 206-210.
Direct Link  |  

6:  Fekety, R., 1997. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am. J. Gastroenterol., 92: 739-750.
Direct Link  |  

7:  Chang, T.W., M. Lauermann and J.G. Bartlett, 1979. Cytotoxicity assay in antibiotic-associated colitis. J. Infect. Dis., 140: 765-770.
Direct Link  |  

8:  Barbut, F., M. Mace, V. Lalande, P. Tilleul and J.C. Petit, 1997. Rapid detection of Clostridium difficile toxin A in stool specimens. Clin. Microbiol. Infect., 3: 480-483.

9:  Lozniewski, A., C. Rabaud, E. Dotto, M. Weber and F. Mory, 2001. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: Usefulness of premier cytoclone A/B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J. Clin. Microbiol., 39: 1996-1998.
CrossRef  |  

10:  O`Connor, D., P. Hynes, M. Cormican, E. Collins, G. Corbett-Feeney and M. Cassidy, 2001. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol., 39: 2846-2849.
CrossRef  |  

11:  Turgeon, D.K., T.J. Novicki, J. Quick, L. Carlson, P. Miller and U. Ulness et al., 2003. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J. Clin. Microbiol., 41: 667-670.
CrossRef  |  

12:  Settle, C.D. and M.H. Wilcox, 1997. Clostridium difficile toxin A detection on colonies. Clin. Microbiol. Infect., 3: 388-389.

13:  Groschel, D.H., 1996. Clostridium difficile infection. Crit. Rev. Clin. Lab. Sci., 33: 203-245.

14:  Barbut, F., V. Lalande, G. Daprey, P. Cohen, N. Marle, B. Burghoffer and J.P. Petit, 2000. Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile associated diseases. Eur. J. Clin. Microbiol. Infect. Dis., 19: 481-484.
Direct Link  |  

15:  Landry, M.L., J. Topal, D. Ferguson, D. Giudetti and Y. Tang, 2001. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples. J. Clin. Microbiol., 39: 1855-1858.
CrossRef  |  

16:  Kelly, C.P. and T.J. LaMont, 1998. Clostridium difficile infection. Ann. Rev. Med., 49: 375-390.

17:  Lyerly, D.M., L.M. Neville, D.T. Evans, J. Fill, S. Allen, W. Greene and R. Sautter et al., 1998. Multicenter evaluation of the Clostridium difficile Tox A/B test. J. Clin. Microbiol., 36: 184-190.
Direct Link  |  

18:  Garner, J.S., 1996. Guideline for isolation precautions in hospitals: The hospital infection control practices advisory committee. Infect. Control. Hosp. Epidemiol., 17: 53-80.
Direct Link  |  

©  2021 Science Alert. All Rights Reserved